Australia markets close in 5 hours 54 minutes

Recce Pharmaceuticals Ltd (RCE.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.66000.0000 (0.00%)
As of 04:10PM AEST. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Selling general and administrative
5,231
5,231
3,367
7,509
1,587
Total operating expenses
17,243
17,243
12,597
15,200
5,260
Operating income or loss
-17,243
-17,243
-12,597
-15,200
-5,260
Interest expense
172.623
172.623
2.416
2.107
45.847
Total other income/expenses net
4,282
4,282
1,532
1,593
974.23
Income before tax
-13,077
-13,077
-10,986
-13,513
-4,317
Income tax expense
0
0
0
0
0
Income from continuing operations
-13,077
-13,077
-10,986
-13,513
-4,317
Net income
-13,077
-13,077
-10,986
-13,513
-4,317
Net income available to common shareholders
-13,077
-13,077
-10,986
-13,513
-4,317
Basic EPS
-0.07
-
-0.06
-0.09
-0.03
Diluted EPS
-0.07
-
-0.06
-0.09
-0.03
Basic average shares
175,714
-
175,871
156,955
128,477
Diluted average shares
175,714
-
175,871
156,955
128,477